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Abstract 
Conversion of residue [3Tyr-297 of the Escherichia coli F~-ATPase (ECF l) to a Cys in the mutant [3Y297C led to impaired oxidative 
phosphorylation based on growth curves. The ATPase activity of ECF t isolated from the mutant [3Y297C was only 1% of wild-type 
activity, but the residual activity involves cooperative multi-site nzyme turnover based on inhibition by DCCD and azide. ATPase 
activity could be increased to 8%, and 13% of wild-type by reaction of the introduced Cys with N-ethyl maleimide (NEM), and 
7-chloro-4-nitrobenzofurazan (NbfC1), respectively, suggesting that enzymatic function is improved by an increased hydrophobicity of
residue [3Cys-297. The mutation [3Tyr-297---, Cys had no effect on nucleotide binding in studies with the fluorescent analog 
lin-benzo-ADP. The asymmetry of ECF I was investigated in the mutants [3Y297C and [3Y297C:E381C/eS108C by examining the 
relative reactivity of Cys-297 in the three copies of the [3 subunit under different nucleotide binding conditions. In agreement with a 
previous tudy (Haughton, M.A. and Capaldi, R.A. (1995) J. Biol. Chem. 270, 20568-20574), the asymmetry was maintained under all 
nucleotide conditions. The NbfC1 reaction site was found to be [3free, which is also the site most reactive to NEM, [3, is the second site 
which reacts with NbfC1 or NEM, while the third site, [3v, is poorly reactive to either eagent. 
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1. Introduction 
The H+-translocating F1F0-ATPase (ATP synthase) di- 
rects the synthesis of ATP from ADP and inorganic phos- 
phate (Pi) in bacteria, mitochondria, nd chloroplasts dur- 
ing oxidative- or photo-phosphorylation [1-4]. In the re- 
verse direction, the enzyme can also generate an ATP 
hydrolysis-driven proton gradient for use in ion transport 
Abbreviations: ECF~, soluble portion of the Escherichia coli FIF 0, 
ATP synthase; ECFIF 0, Escherichia coli FIF o ATP synthase; CF i, 
soluble portion of the chloroplast FiF0-ATPase; MF I, soluble portion of 
the mitochondrial FIF0-ATPase; TF 1 , soluble portion of the thermophilic 
bacterium PS3 F IF0-ATPase; CM, N-[4-[7-(diethylamino)-4- 
methyl]coumarin-3-yl] maleimide; Mops, 3-(N-morpholino)propan- 
esulfonic acid; NEM, N-ethylmaleimide; DCCD, dicyclohexyl carbo- 
diimide; NbfCl, 7-chloro-4-nitrobenzofurazan; AMP.PNP, 5'-adenylyl- 
[3,'y-imidodiphosphate; DTT, dithiothreitol; SDS, sodium dodecyl sulfate; 
Me2SO, dimethyl sulfoxide; PAGE, polyacrylamide gelelectrophoresis. 
* Corresponding author. Fax: + 1 (541) 3464854. 
processes. The F1F 0 from Escher ich ia  coli  (ECFIF 0) is a 
multi-subunit complex of molecular weight 530000 Da. 
The F~ part is composed of five subunits ((x, 13, ~/, 8, and 
e, in the stoichiometry 3:3:1:1:1), while the F 0 part is 
composed of three different subunits (a, b, and c, in the 
ratio 1:2:10-12). They are linked by a stalk region com- 
prised of subunits from both F 1 (% 8, and e) and F 0 (b) 
[4-7]. 
Earlier electron microscopy studies of ECFj [8,9], and 
the recent X-ray structure determination of MF 1 from 
bovine heart mitochondria [10], show that the eL and 13 
subunits alternate in a hexagonal arrangement around a 
central cavity that encloses a part of the ~ subunit. The 
catalytic sites are located primarily on the 13 subunits. 
Additional nucleotide binding sites are present on the eL 
subunits that may play a structural rather than a catalytic 
role. The crystal form of the enzyme reported by Abra- 
hams et al. [10] shows an asymmetry of the three a-13 
subunit pairs that is reflected both in different nucleotide 
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occupancies of the catalytic sites and different interactions 
of each ct-13 pair with the ~ subunit. ATP synthesis and 
hydrolysis are highly cooperative processes involving three 
catalytic sites [4,11]. Evidence from genetic [12-14], bio- 
chemical [15-18], and structural studies [10,19] supports a
key role for the ",/ subunit in both catalytic ooperativity 
and energy coupling. 
A number of nucleotide analogs have been used to 
explore the properties of the catalytic sites in F~-ATPases, 
including 8-azido ATP and NbfC1, both of which have 
been shown to modify 13Tyr-297 of ECF 1 or the homolo- 
gous residues of MF 1, TF 1 or CF 1 (13Tyr-311, 13Tyr-307, or 
13Tyr-328 respectively), and inhibit enzyme activity essen- 
tially fully [20-25]. In apparent contradiction, Odaka et al. 
[26] have reported that conversion of Tyr-307 (the equiva- 
lent of Tyr-297) to a Cys in TF l has no effect on activity. 
To learn more about any possible functions of Tyr-297, we 
have mutated this residue to a Cys in ECF 1. Incorporation 
of a Cys in the 13 subunit also allows us to study the 
asymmetry of the enzyme by examining the relative reac- 
tivity of this residue in the different 13 subunits of ECF l 
under different nucleotide conditions. 
2. Materials and methods 
2.1. Strains and construction of plasmids containing muta- 
tions in the uncD and uncC genes 
A 1.01-kb NcoI fragment encoding the COOH-terminal 
part of the 13 subunit was isolated from the unc-operon 
containing plasmid pRA100 and inserted into M13mpl8 
(New England Biolabs) for the site-directed mutagenesis 
step as described in Aggeler et al. [27]. The oligonucleo- 
tide CATCCGCAGGTACGCATACTGCCTGTAC was 
used to replace a tyrosine with a cysteine at position 13297 
[28]. Incorporation of the mutation was determined by 
DNA sequence analysis (Center for Gene Research and 
Biotechnology, Oregon State University, OR), and by re- 
striction enzyme analysis (destroyed AccI site). The 1.01- 
kb fragment containing the 13Y297C mutation was re-in- 
serted into pRA100 to form pRAI30. The mutant 
13Y297C:E381C/eS108C was constructed from a combi- 
nation of the 13Y297C mutation with mutations in the 
DELSEED region of 13 (Glu-381 ~ Cys) and in e (Ser-108 
Cys) to form the plasmid pRA144. Subcloning was 
carried out by ligation of the 6.74-kb EagI/EagI  frag- 
ment of pRA130 (containing 13Y297C) to the 5.94-kb 
Eag I /Eag I  fragment of pRA134 (containing 
13E381C/eS108C, [27]. The unc- E. coli strain AN888 
was transformed with the plasmids pRA130 and pRA144 
for expression of mutant ECF 1. The plasmid pAN45, and 
E. coli strains AN1460 (wild-type) and AN888, were the 
generous gift of Graeme B. Cox, The Australian National 
University, Canberra [ 16,29[. 
2.2. Growth of mutant strains and preparation of ECF I 
Analysis of growth yields was determined in minimal 
liquid media (0.1 M KPi 93 mM NH4C1, 0.8 mM Na2SO 4, 
pH 7.5, 1.6 mM MgC12, 3.6 IxM FeSO 4, 14.8 IxM thi- 
amine) supplemented with 100 mM succinate. ECF 1 was 
isolated and stored as previously described [9,30]. Immedi- 
ately prior to use, enzyme was precipitated with 70% 
ammonium sulfate and transferred to an EDTA-containing 
buffer, either 50 mM Mops, pH 7.0, 0.5 mM EDTA, 10% 
glycerol (buffer A), 50 mM Tris-HC1, pH 8.0, 0.5 mM 
EDTA, 10% glycerol (buffer B), or 50 mM Tris-HC1, pH 
7.5, 0.5 mM EDTA, 10% glycerol (buffer C), and passed 
through two consecutive centrifuge columns in order to 
remove loosely bound nucleotides, as previously described 
[161. 
2.3. Equilibrium binding experiments with lin-benzo-ADP 
and calculation of apparent binding constants 
Fluorescence measurements were performed using a 
SLM 8000 photon counting spectrofluorometer (SLM Inc., 
IL), at an excitation wavelength of 331 nm and an emis- 
sion wavelength of 390 nm. Wild-type or mutant (13Y297C) 
ECF~ in buffer B was supplemented with MgCI 2 (2.5 mM) 
and diluted into buffer D (50 mM Tris-HC1, pH 8.0, 2.0 
mM MgC12) prior to addition of lin-benzo-ADP (the 
generous gift of Alan E. Senior, University of Rochester 
Medical Center, Rochester, NY). Concentrations of lin- 
benzo-ADP were determined spectrophotometrically at 331 
nm using an extinction coefficient of 9750 M- l  cm-1 
[31]. ECF l (50 nM to 3.5 I~M) was added to a given 
concentration of lin-benzo-ADP in separate xperiments 
over a concentration range spanning three orders of magni- 
tude (150 nM to 20 ~M) and incubated at room tempera- 
ture until binding equilibrium was reached (approx. 1 h). 
The concentrations of bound and free lin-benzo-ADP were 
then determined for each concentration of enzyme-bound 
nucleotide and the intrinsic binding constants calculated 
from a plot of [free lin-benzo-ADP] vs. [bound lin-benzo- 
ADP]/[F 1 ] as previously described in Weber et al. [32]. A 
curve fit which assumed three independent binding sites 
was applied using the KaleidaGraph TM data analysis and 
graphics program for personal computer, based on Eq. 1: 
number of ligands bound/mol F 1 = c / (gd l  + C) -[- 
C/(Ka2 + C) + C/(Kd3 + C), where, Kal, Kd2 , and Kd3 
= intrinsic binding constants for nucleotide binding sites 
1, 2 and 3, respectively, and C = [free lin-benzo-ADP] 
(see also Refs. [32,33]). 
2.4. Chemical modification reactions and determination of
ATPase activity 
Reactions of mutant (13297C) and wild-type ECF1 (2 
p~M) with DCCD (500 ~M), NEM (200 p~M) and CM 
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(200 IxM) were performed in buffer A supplemented with 
5 mM ATP (DCCD) or 5 mM ATP+5.5  mM MgC12 
(NEM and CM), for 2-3 h at 23°C. Reaction with NbfC1 
was performed at either pH 7.5 (buffer C, wild-type) [23] 
or pH 7.0 (buffer A, mutant) [34] for 1 h at 30°C, then 
excess reagent was removed by column centrifugation. 
Aliquots of NbfCl-modified enzyme were removed for 
treatment with DTT (20 mM, 2 h), activity measurements 
and analysis by SDS-PAGE. Untreated aliquots of mutant 
and wild-type ECF~ were subjected to the same buffer and 
incubation conditions to control for any loss of activity 
throughout this period of time. Aliquots of each reaction 
mixture (5 Ixg/ml) were withdrawn at the conclusion of 
incubation periods and the ATPase activity assayed imme- 
diately using an ATP regenerating system at pH 8.0, 2 mM 
ATP and 2 mM MgCI 2 (modified from Ref. [35]). In a 
separate xperiment, NaN 3 (final concentration 2 mM) was 
added directly to aliquots of unmodified F l in the assay 
cuvette in order to determine the inhibitory effect of NaN 3 
on ATPase activity. Aliquots of both CM-modified and 
NbfCl-modified enzyme were quenched with 10 mM NEM 
then subjected to SDS-PAGE (in the absence of reducing 
agent) and UV illumination of separated [3 subunits in 
order to qualitatively confirm the covalent incorporation of 
reagent. 
2.5. Incorporation of [ /4 C]NEM and calculation of kinetic 
constants 
Mutant ([3297C) ECF l (l IxM) was incubated with 
[14C]NEM (DuPont NEN: spec. act. 40.0 mCi/mmol), at 
either 20 txM or 200 txM, in buffer A, in the presence or 
absence of various nucleotides, for varying periods of time 
up to 3 h at room temperature. Nucleotide was added to 
give aliquots containing 5 mM ATP + 5.5 mM MgCI 2 
(ATP+Mg2+),  5 mM ATP+0.5  mM EDTA (ATP+ 
EDTA), 5 mM ADP + 5.5 mM MgC12 + 5 mM NaH2PO 4 
(ADP+Mg 2++Pi), and 5 mM AMP-PNP+5.5 mM 
MgC12 (AMP-PNP+Mg2+).  For determinations per- 
formed in the absence of added nucleotide, the reaction 
was carried out in buffer A (EDTA). Following 15-30 min 
equilibration at room temperature, 200 IxM [~4C]NEM (2.9 
mM stock in Me2SO, spec. act. 40.0 mCi/mmol) was 
added to aliquots of known protein concentration, both in 
the presence and absence of 2% SDS. Aliquots were 
withdrawn at specific time intervals (15 s through 30 rain) 
and quenched at each time point by the addition of 10 mM 
NEM. These were then applied to a 10-18% linear gradi- 
ent SDS-PAGE for determination of the molar incorpora- 
tion of [14C]NEM into [3 subunits [30,36]. Briefly, samples 
labeled in SDS were used to calculate how many c.p.m. 
would be expected in any Cys when one mol of [~4C]NEM 
is incorporated. This determination is based on there being 
4 Cys in the ~ subunit and 2 in the -/ subunit, all of which 
are available for reaction in the detergent-treated samples. 
The rate of incorporation of NEM into [3Cys-297 was 
described by kinetic rate constants which assume pseudo- 
first order reactions of one, two or three independently 
reacting Cys residues as previously described [33,37]. 
2.6. CuCI~ induced cross-link formation in the mutant 
[3 Y297C:E381C/ eSI08C 
Prior to induction of disulfide bond cross-links, selec- 
tive modif ication of Cys-297 in the mutant 
[3Y297C:E381C/eS108C, in only l tool of [3 subunits, 
was carried out by reaction of ECF~ (10 IxM) with 
[14C]NEM (20 IxM) in the presence of ATP+ Mg 2+. 
After incubation for 1 min, further incorporation of NEM 
was stopped and excess reagent and nucleotides removed 
by passage through two consecutive centrifuge columns 
equilibrated in buffer A. The eluate was divided into three 
aliquots, one of which received no further treatment and 
was used to calculate molar incorporation of NEM; a 
second aliquot was treated with 100 IxM CuCl 2 (in the 
presence of 2.5 mM MgC12) to induce disulfide bond 
cross-links, while a third aliquot was reacted with 200 txM 
[~4C]NEM, in the presence of 2% SDS, for calibration 
purposes. The incorporation of NEM into [3 subunits 
(tool/tool F 1), i.e., both free [3 (including a small incorpo- 
ration into [3-g) and cross-linked [3 subunits ([3-~ and [3-~), 
was determined from gel slices isolated by SDS-PAGE (in 
the absence of DTT) as previously described [37]. 
2.7. Other procedures and materials 
The BCA protein assay was from Pierce. SDS-PAGE 
was performed with a 4% stacking gel and 10-18% linear 
gradient separating el [38]. NEM, DCCD, and NbfCl 
were from Sigma, and CM from Molecular Probes. 
3. Results 
3.1. The ¢3 Tyr297--* Cys mutation gives reduced growth 
and altered ATPase activi~ 
The mutant [3Y297C proved to grow only poorly rela- 
tive to the isogenic wild-type strain (pRA100/AN888) in 
minimal liquid media supplemented by succinate, indicat- 
ing an impairment of oxidative phosphorylation. Thus at 
18 h when the optical density of wild-type had reached 1.8 
(the maximum), that of the mutant was 0.6. The ATPase 
activity of ECF l isolated from the mutant was also 
markedly reduced, i.e., 0.15-0.25 p~mol ATP hydrolyzed 
min ~mg -~, compared with wild-type ATPase activity of 
16-20 p~mol ATP min ~mg -~, when assayed at pH 8.0 in 
the presence of 2 mM ATP and 2 mM MgC12. While this 
ATPase activity of ECF~ from the mutant [3Y297C is only 
around 1% of wild-type, the rate is still approx. 104-fold 
higher than the reported rate of uni-site catalysis by ECF l 
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Fig. 1. Equilibrium binding of lin-benzo-ADP to wild-type and mutant 
(13Y297C) ECF I. The results of several equilibrium binding experiments 
are shown in which wild-type (open circles) or mutant (closed circles) 
ECF 1 (0.05-3.5 IzM)were incubated with lin-benzo-ADP (0.15-20 llM) 
in buffer D until no further decrease in fluorescence intensity relative to 
free lin-benzo-ADP was observed, i.e., equilibrium conditions were 
reached. The relative emission intensity was recorded for each concentra- 
tion of enzyme-bound lin-benzo-ADP and intrinsic binding constants 
calculated from computer-generated curve fits (solid line, wild-type only 
shown) as described in the text. 
[39], implying that the mutant enzyme is competent in 
(slow) multi-site catalysis. 
Higher concentrations of DCCD (500 ~M) inhibited the 
ATPase activity of the mutant 3Y297C to less than 0.05 
t~mol ATP rain- ~ mg 1, i.e., by approx. 75% while inhibi- 
tion by NaN 3 (2 mM) was 45% cf. 90% for wild-type 
enzyme. The inhibitory effect of these two reagents, both 
of which affect multi-site but not uni-site catalysis, is 
further evidence that the low but significant ATPase activ- 
ity of the mutant 13Y297C involves cooperative, multi-site 
enzyme turnover [40-42]. The low activity of the mutant is 
not a result of an altered subunit composition. SDS-PAGE 
of ECF~ from the mutant 13Y297C showed the same 
subunit pattern as wild-type enzyme. There was no major 
loss of 7, 8, or • subunits (see later). Moreover, the low 
activity does not appear to be due to an altered affinity for 
nucleotide, based on experiments with lin-benzo-ADP. 
This fluorescent analog has been shown to bind to wild-type 
ECF 1 with a stoichiometry of 3 mol/mol F 1 [32,43]. Fig. 1 
compares data from equilibrium binding experiments using 
the mutant 13Y297C and wild-type ECF,. No significant 
difference in nucleotide binding between the mutant and 
wild-type enzyme was detected. The binding constants 
obtained from computer curve fitting were Kdl = < 0.15 
I~M, Kd2 and Kd3 = 1.4 tzM (wild-type), and Kdl = < 
0.15 I~M, Kd2 and Ko3 = 2.7 I~M (mutant), in both cases, 
values slightly higher than, but comparable to published 
values [32]. 
3.2. NbfC1 reacts with and activates the mutant fl Y297C 
To further explore the inhibitory effect of the Cys for 
Tyr replacement at position 13297, the mutant 13Tyr-297 
was reacted with different sulfydryl reagents to vary the 
side chain group with respect o size and hydrophobicity. 
The smallest reagent tested, NEM, increased ATPase activ- 
ity approx. 5-fold. NbfC1 also modified the mutant 
[3Y297C. This reagent reacts equally well with Cys residues 
as with Tyr [34]. While NbfC1 modification of Tyr at [3297 
inhibited activity by 95%, reaction of the Cys at the same 
position with this reagent gave a six-fold increase of 
ATPase activity to 1.5 I~mol ATP hydrolyzed min- '  mg ' 
protein, which is approx. 13% of the activity of wild-type 
enzyme. DTT treatment to release NbfC1 from the Cys [44] 
caused loss of activity back to the rate obtained with 
unmodified mutant [3Y297C. In contrast o the activation 
obtained with NEM or NbfC1, the bulky maleimide CM 
reacted with 13Cys-297, (based on fluorescence labeling of 
the 13 subunit, result not shown), but the modification had 
no effect on activity. 
3.3. Asymmetry of the fl subunits based on reactivity of 
[3Cys-297 to NEM 
Introduction of a Cys for a Tyr at position 297 produced 
a site for chemical modification i  all three 13 subunits, the 
reaction of which is a measure of 13 subunit equivalency. 
To examine the environment of Cys-297 in the different 13 
subunits, ECF, from the mutant enzyme was incubated 
with [~4C]NEM (20 or 200 I~M) for different lengths of 
time, the reaction quenched with cold NEM (20 raM), and 
then the incorporation of radioactivity analyzed by SDS- 
PAGE. As described previously, [14C]NEM labeled the c~ 
subunit to a small extent and the 8 subunit of ECF~ to 
0.7-0.9 mol/mol F, when wild-type enzyme was exam- 
ined [36]. Reaction of the mutant ECF 1 with low concentra- 
tions of [14C]NEM labeled the oL and 8 subunits, as in 
wild-type enzyme. In addition, there was labeling of the 13 
subunit by modification of the Cys introduced at residue 
297. 
One mol of NEM per mol F, was incorporated into the 
[3 subunits very rapidly in all experiments. The kinetic rate 
constant for reaction of this first site was 2200 M- ~ s ' in 
the presence of ATP + Mg 2+, 1500 M- i s  J in the pres- 
ence of ADP+Mg+2+pi ,  and 1370 M- i s  -j in the 
presence of ATP + EDTA. The constants were calculated 
from computer-fitted curves such as shown in Fig. 2, 
where each point represents the mean of 3-4 different 
experiments. The coefficient of variation between experi- 
ments was calculated to be approx. 15%. These kinetic rate 
constants only approximate he second order rate constant, 
as they are determined at only one or two concentrations 
of NEM. They compare with a (real) second order rate 
constant of 1600 M- is  ' for the reaction of NEM with 
free cysteine [45], which suggests that Cys-297 of one of 
the three [3 subunits is exposed to solvent and readily 
available for reaction under all nucleotide conditions. The 
reaction of Cys-297 of a second [3 subunit varied much 
more dramatically with nucleotide conditions as evidenced 
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Fig. 2. Incorporation of [14C]NEM into 13 subunits of mutant ECF1 
(13Y297C) under different nucleotide conditions. The rates of incorpora- 
tion of [14C]NEM into 13Cys-297 were determined over a 60-min time 
course (10 min shown) by reaction of ECF I (1 b~M) with  20 IxM 
[14C]NEM in buffer A supplemented with nucleotides, ATP+Mg 2+ 
(squares), ADP + Mg 2 + + Pi (open circles), or AMP-PNP + Mg2 + (closed 
circles), as described in the text. The mean of 3-4 independent experi- 
ments is plotted, with error bars representing 1 standard deviation. The 
solid lines are computer-generated curve fits from which kinetic rate 
constants were determined for each nucleotide condition assuming three 
independently reacting Cys residues (ATP+Mg 2+ ), or a single reactive 
site (ADP+Mg 2+ +Pi). 
portion of [~f ree  becomes cross-linked to the 8 subunit 
[27,37], the extent of incorporation into this 13 subunit was 
determined as the sum of the [14C]NEM in both uncross- 
A 
in Fig. 2. Thus a second mol of NEM was incorporated 
into the mutant enzyme fairly rapidly in the presence of 
ATP+Mg 2÷, (k 2=315 M ls-1).  In ATP+EDTA this 
rate was 40 M-~s -~, while in the presence of ADP + 
Mg +2 + P~ or AMP-PNP + Mg +2 reaction of NEM into a 
second Cys was negligible. With a high concentration of 
[14C]NEM (200 I~M) for prolonged times (i.e., 2 -3  h), the 
third copy of Cys-297 could be modified (rate constant 
around 15 M-~s ~) in ATP+Mg +2. This site was unre- 
active under all other nucleotide conditions. 
In a second set of experiments, NEM incorporation into 
different 13 subunits was examined using the mutant 
13Y297C:E381C/eSI08C. The distribution of [14C]NEM 
between the different 13 subunits was obtained by reacting 
ECF~ from this mutant with 20 IzM reagent. An incubation 
time of 1 min was used, in which close to one mol of 
reagent was incorporated (see Fig. 2), in order to preferen- 
tially label only the fastest reacting copy of [3Cys-297. 
Under these same conditions, the labeling of 13 Cys 381 
and ~ Cys 108 in the double mutant 13E381C/~S108C was 
less than 0.1 mol per Cys residue (result not shown). 
Samples were then treated with CuE12 to cross-link one [3 
subunit to y (13~) and a second to e (13,) (Fig. 3A). As 
shown in Fig. 3B, most of the first mol of [14C]NEM to be 
incorporated into the enzyme was in 13f~e, i.e., that 13 
subunit not associated with the ~ or e subunits. As a 
1 2 
,oQ-  
O 
O 
Z 
l 
13 13--v 
Fig. 3. Incorporation of 1 mol of [14C]NEM into 13Cys-297 of mutant 
ECF1 (13Y297C:E381C/~S108C) followed by cross-linking. Mutant 
ECF I (10 ~zM) (13Y297C:E381C/~SI08C) was labeled with [IaC]NEM 
(20 IxM) for 1 min in buffer A supplemented with ATP+Mg 2+ and 
disulfide bond cross-links induced between 13 subunits and % 8, and c 
subunits, as described in the text. Aliquots of cross-linked (lane 1) and 
non-cross-linked enzyme (lane 2) (50 txg per lane) were subjected to  
SDS-PAGE in the absence of DTT and stained with Coomassie brilliant 
blue R. The molar incorporation of [ 14 C]NEM (mol/mol F I ) into individ- 
ual 13 subunits-13 subunit ([3fr~e), and cross-linked subunits, 13-y (13~), 
and 13-~ (13,) was determined. A small amount of incorporation i to the  
13-8 cross-link product was added to 13fr~, as described in the text. 
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linked [3 and in the [3-8 product. There was a small 
amount of labeling of [3~ but no labeling of [3~. A similar 
distribution of label was observed when the experiment 
was carried out with NbfC1 (at pH 7.0), and the incorpora- 
tion of label monitored by UV illumination of [3 subunits 
separated by SDS-PAGE (result not shown). 
When the length of time of reaction of the mutant 
enzyme with [14C]NEM prior to cross-linking was in- 
creased to 5 min or more to ensure incorporation of closer 
to 2 mol of reagent, the yield of cross-linked products 
dropped significantly. This is because of NEM modifica- 
tion of 13 Cys 381 and • Cys 108, as indicated by 
experiments with the double mutant [3E381C/¢S108C 
(result not shown). However, there was still little or no 
incorporation f[ 14C]NEM (less than 0.05 mol) in that [3-y 
cross-linked product formed (yield 50-60%), confirming 
that it is the reaction of Cys 297 of [3~ which is most 
influenced by nucleotide occupancy. 
4. Discussion 
Modification of [3Tyr-297 by NbfCl has been shown to 
inhibit the ATPase activity of F1-ATPases [20], implying 
an important role of this residue. As Tyr-297 is the site of 
binding of 8-azido ATP [21], it was suggested that this 
residue is in the catalytic site and involved in substrate 
binding [46]. In contrast, Odaka et al. [26] reported that 
Tyr-307 (the equivalent residue to Tyr-297) can be changed 
to a Cys in TF~ by site-directed mutagenesis without 
affecting activity. 
We have now converted Tyr-297 to a Cys in ECF 1 and 
find that this mutation dramatically affects activity, giving 
an enzyme with only around 1% of the ATPase activity of 
wild-type. The Cys for Tyr change did not affect nu- 
cleotide binding based on equilibrium binding studies with 
lin-benzo-ADP. This result would be predicted by the 
recent X-ray structure determination of MF 1, which shows 
Tyr-311 (equivalent of Tyr-297) approx. 5 A from the 
nucleotide binding site [10]. 
Our data indicate that the mutant [3Y297C retains coop- 
erative or multi-site ATPase activity, albeit low, which is 
inhibited by DCCD and azide. The ATPase activity of the 
mutant enzyme could be increased to as high as 13% of 
that of wild-type by modification of the introduced Cys by 
NbfC1, which added to the bulk and increased the hy- 
drophobicity of the side chain. The reaction of NbfCl with 
Cys-297 was reversed by reaction with DTT, confirming 
that the reagent had reacted with the Cys. CM also reacted 
with Cys-297, but failed to activate the enzyme, indicating 
that the size and/or shape of this side chain is important. 
Parsonage t al. [47] have shown that the mutation 13Y297F 
has only minimal effect on activity, supporting the idea 
that hydrophobicity rather than the side chain function is 
critical. Tyr-297 is at the carboxy terminus of 13-sheet 7 of 
the catalytic site domain and leads into an extended loop 
(residues 298-305) that binds the y subunit [10]. It may be 
that a relatively small hydrophobic side chain is required 
to optimize the interaction of this region with the "y 
subunit, and at the same time, allow the movement of the 
y subunit hat occurs during the catalytic ycle. 
Modification of the Cys at 297 in the mutant ECF 1 by 
NEM was shown to occur differently with the three [3 
subunits. Cys-297 of one 13 subunit reacted very rapidly, 
that of a second [3 subunit was very much slower, while 
the reaction in the third [3 subunit was negligible. This 
asymmetry of the [3 subunits was observed when the 
catalytic sites were empty of nucleotide and with ATP or 
ADP bound.  Exper iments  with the mutant  
[3Y297C:E381C/eSI08C, in which CuC12 induces disul- 
fide bond formation between one [3 and y and a second [3 
and e, allowed us to distinguish the different [3 subunits by 
their interaction with the single copy subunits. Labeling of 
this mutant, followed by cross-linking, located the Cys-297 
that reacts most readily with NEM or NbfC1 in [3free, i.e., 
that [3 subunit which does not become linked to either y or 
• subunit by the CuC12 treatment. The rate of NEM 
incorporation i to this site was in the same range observed 
for free cysteine in solution, indicating that Cys-297 in 
[3free is exposed to solvent. 
The second site to react with NEM is located on [3c 
Cys-297 in this 13 subunit was partly shielded and its 
reaction very much nucleotide-dependent. Its modification 
was quite fast in ATP + Mg 2÷, but essentially non-existent 
in ADP ÷ Mg 2÷ or AMP-PNP + Mg 2+ under the experi- 
mental conditions employed. Given the significant, if low, 
ATPase activity of the mutant [3Y297C, and activation by 
incorporation of NEM, the enzyme will be turning over 
during the reaction time (30 min) of the reagent, when 
there is 5 mM ATP present. Only under these turnover 
conditions is there reaction of two and probably three [3 
subunits at Cys-297. However, such continuous enzyme 
turnover did not equalize the sites; they retained ifferent 
rates of NEM modification. This result is hard to explain 
by a binding change mechanism (e.g., Boyer [4]), in which 
the 13 subunits cycle through each of the different possible 
conformations with every two or three turnovers of the 
enzyme during bi-site or tri-site catalysis. 
Recently Schmidt and Senior [48] have described exper- 
iments in which they modify a mutant of ECF 1 [3S339C 
with [14C]NEM. They find that one mol of reagent reacts 
with Cys-339 rapidly in an apparently nucleotide indepen- 
dent manner, while the second mol of reagent o bind is 
nucleotide-sensitive, b ing rapid if there is enzyme turnover 
during the labeling (ATP+Mg2+),  slower in ADP+ 
Mg 2÷, and extremely slow in AMP-PNP + Mg 2+. These 
authors do not distinguish the sites of reaction, but it is 
likely that the first Cys-339 to react is in [3free and the 
second in [3,. The explanation of the nucleotide depen- 
dence observed here for Cys-297, and by Schmidt and 
Senior [48] for Cys-339, is not obvious at present, but may 
involve shielding of these residues in [3~ by interactions of 
160 M.A. Haughton, R.A. Capaldi / Biochimica et Biophysica Acta 1276 (1996) 154-160 
the "y subunit, which are altered by turnover and move- 
ments of the 2~ subunit. 
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